{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:53:56Z","timestamp":1794452036721,"version":"4.9.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ymgme.2025.109197","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T23:23:01Z","timestamp":1753399381000},"page":"109197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Phosphodiesterase type 5 inhibition as a therapeutic strategy in primary mitochondrial disease: Evidence from patient fibroblasts and clinical observations"],"prefix":"10.1016","volume":"146","author":[{"given":"Graeme","family":"Preston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Elsharkawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Morava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Kozicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ymgme.2025.109197_bb0005","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/1873-3468.13995","article-title":"Mitochondrial disorders of the OXPHOS system","volume":"595","author":"Fernandez-Vizarra","year":"2021","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2025.109197_bb0010","series-title":"Annual Review of Neuroscience","first-page":"91","article-title":"Mitochondrial Disorders in the Nervous System","volume":"31","author":"DiMauro","year":"2008"},{"issue":"12","key":"10.1016\/j.ymgme.2025.109197_bb0015","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMra1012478","article-title":"Monogenic mitochondrial disorders","volume":"366","author":"Koopman","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109197_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mito.2009.09.006","article-title":"Energetics, epigenetics, mitochondrial genetics","volume":"10","author":"Wallace","year":"2010","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109197_bb0025","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neubiorev.2013.02.005","article-title":"Mitochondria and the economy of stress (mal)adaptation","volume":"37","author":"Morava","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109197_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2005.12.001","article-title":"Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders","volume":"3","author":"Smeitink","year":"2006","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109197_bb0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10545-018-0168-1","article-title":"The role of suboptimal mitochondrial function in vulnerability to post-traumatic stress disorder","volume":"41","author":"Preston","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109197_bb0040","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0006-291X(05)80860-5","article-title":"A point mutation in the mitochondrial tRNALeu(UUR) gene in melas (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes)","volume":"173","author":"Kobayashi","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109197_bb0045","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/brain\/awl389","article-title":"SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness","volume":"130","author":"Carrozzo","year":"2007","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.ymgme.2025.109197_bb0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.nmd.2005.09.005","article-title":"Mutations in mtDNA-encoded cytochrome c oxidase subunit genes causing isolated myopathy or severe encephalomyopathy","volume":"15","author":"Horv\u00e1th","year":"2005","journal-title":"Neuromuscul. Disord."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109197_bb0055","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","article-title":"Reactive oxygen species and the central nervous system","volume":"59","author":"Halliwell","year":"1992","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109197_bb0060","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.91.4.955","article-title":"Cardiac involvement in mitochondrial diseases","volume":"91","author":"Anan","year":"1995","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109197_bb0065","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/MOP.0000000000000686","article-title":"Mitochondrial disease genetics update: recent insights into the molecular diagnosis and expanding phenotype of primary mitochondrial disease","volume":"30","author":"McCormick","year":"2018","journal-title":"Curr. Opin. Pediatr."},{"issue":"14","key":"10.1016\/j.ymgme.2025.109197_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11144209","article-title":"Primary and secondary mitochondrial diseases: etiologies and therapeutic strategies","volume":"11","author":"Valenti","year":"2022","journal-title":"J. Clin. Med."},{"issue":"23","key":"10.1016\/j.ymgme.2025.109197_bb0075","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1093\/hmg\/ddn265","article-title":"The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2","volume":"17","author":"Sasarman","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"6302","key":"10.1016\/j.ymgme.2025.109197_bb0080","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/348651a0","article-title":"A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies","volume":"348","author":"Goto","year":"1990","journal-title":"Nature"},{"issue":"38","key":"10.1016\/j.ymgme.2025.109197_bb0085","doi-asserted-by":"crossref","first-page":"E4033","DOI":"10.1073\/pnas.1414028111","article-title":"Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming","volume":"111","author":"Picard","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109197_bb0090","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MOP.0000000000000954","article-title":"Mitochondrial medicine therapies: rationale, evidence, and dosing guidelines","volume":"32","author":"Barcelos","year":"2020","journal-title":"Curr. Opin. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109197_bb0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40291-020-00510-6","article-title":"Current and emerging clinical treatment in mitochondrial disease","volume":"25","author":"Tinker","year":"2021","journal-title":"Mol. Diagn. Ther."},{"issue":"13","key":"10.1016\/j.ymgme.2025.109197_bb0100","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/bph.14205","article-title":"PDE5 inhibitors \u2013 pharmacology and clinical applications 20 years after sildenafil discovery","volume":"175","author":"Andersson","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109197_bb0105","first-page":"407","article-title":"Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction","volume":"38","author":"Huang","year":"2013","journal-title":"P t"},{"key":"10.1016\/j.ymgme.2025.109197_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111128","article-title":"Phosphodiesterase 5 (PDE5): structure-function regulation and therapeutic applications of inhibitors","volume":"134","author":"Ahmed","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymgme.2025.109197_bb0115","series-title":"StatPearls","article-title":"PDE5 Inhibitors","author":"Dhaliwal","year":"2025"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109197_bb0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.RES.0000152262.22968.72","article-title":"cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism","volume":"96","author":"Takimoto","year":"2005","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109197_bb0125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","article-title":"Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents","volume":"109","author":"Lugnier","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymgme.2025.109197_bb0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biocel.2013.12.009","article-title":"Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome","volume":"48","author":"El-Hattab","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109197_bb0135","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.WNL.0000151976.60624.01","article-title":"L-arginine improves the symptoms of strokelike episodes in MELAS","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109197_bb0140","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.58.5.827","article-title":"Effects of L-arginine on the acute phase of strokes in three patients with MELAS","volume":"58","author":"Koga","year":"2002","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109197_bb0145","doi-asserted-by":"crossref","first-page":"H1558","DOI":"10.1152\/ajpheart.00865.2013","article-title":"Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO\/SIRT1\/PGC-1\u03b1 signaling","volume":"306","author":"Koka","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109197_bb0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10545-010-9081-y","article-title":"Biochemical diagnosis of mitochondrial disorders","volume":"34","author":"Rodenburg","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109197_bb0155","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bbadis.2016.10.028","article-title":"The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model","volume":"1863","author":"Frey","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109197_bb0160","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1042\/CS20140705","article-title":"Novel MTND1 mutations cause isolated exercise intolerance, complex I deficiency and increased assembly factor expression","volume":"128","author":"Gorman","year":"2015","journal-title":"Clin. Sci."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109197_bb0165","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0005-2728(00)00180-8","article-title":"Succinate: quinone oxidoreductases: new insights from X-ray crystal structures","volume":"1459","author":"Lancaster","year":"2000","journal-title":"Biochimica et Biophysica Acta (BBA) - Bioenergetics"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109197_bb0170","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/emmm.201100626","article-title":"Aminoacyl-tRNA synthetases in medicine and disease","volume":"5","author":"Yao","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109197_bb0175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/jhg.2013.143","article-title":"A novel homozygous YARS2 mutation causes severe myopathy, lactic acidosis, and sideroblastic anemia 2","volume":"59","author":"Nakajima","year":"2014","journal-title":"J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109197_bb0180","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajhg.2010.06.001","article-title":"Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia--MLASA syndrome","volume":"87","author":"Riley","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2025.109197_bb0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1750-1172-8-193","article-title":"Phenotypic variability and identification of novel YARS2 mutations in YARS2 mitochondrial myopathy, lactic acidosis and sideroblastic anaemia","volume":"8","author":"Riley","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109197_bb0190","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0039-6257(91)90110-2","article-title":"Leber\u2019s hereditary optic neuropathy and Kearns-Sayre syndrome: mitochondrial DNA mutations","volume":"35","author":"Phillips","year":"1991","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ymgme.2025.109197_bb0195","series-title":"GeneReviews(\u00ae)","article-title":"Single large-scale mitochondrial DNA deletion syndromes","author":"Goldstein","year":"1993"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109197_bb0200","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.410210607","article-title":"Progressive cytochrome c oxidase deficiency in a case of Kearns-Sayre syndrome: morphological, immunological, and biochemical studies in muscle biopsies and autopsy tissues","volume":"21","author":"Bresolin","year":"1987","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109197_bb0205","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ng.2325","article-title":"Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness","volume":"44","author":"Wortmann","year":"2012","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109197_bb0210","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mito.2006.12.004","article-title":"Population prevalence of the MELAS A3243G mutation","volume":"7","author":"Manwaring","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymgme.2025.109197_bb0215","article-title":"Pathogenic mitochondrial DNA 3243A>G mutation: from genetics to phenotype","volume":"13","author":"Li","year":"2022","journal-title":"Front. Genet."},{"issue":"24","key":"10.1016\/j.ymgme.2025.109197_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417186","article-title":"MELAS-derived neurons functionally improve by mitochondrial transfer from highly purified mesenchymal stem cells (REC)","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.ymgme.2025.109197_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162593","article-title":"Varied responses to a high m.3243A>G mutation load and respiratory chain dysfunction in patient-derived cardiomyocytes","volume":"11","author":"Ryytty","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109197_bb0230","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1124\/mol.107.040212","article-title":"Conformational variations of both phosphodiesterase-5 and inhibitors provide the structural basis for the physiological effects of vardenafil and sildenafil","volume":"73","author":"Wang","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"6953","key":"10.1016\/j.ymgme.2025.109197_bb0235","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature01914","article-title":"Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules","volume":"425","author":"Sung","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109197_bb0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/jpet.107.133405","article-title":"Phosphorylation increases affinity of the phosphodiesterase-5 catalytic site for tadalafil","volume":"325","author":"Bessay","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109197_bb0245","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0092-8674(77)90286-0","article-title":"Mouse L cell mitochondrial DNA molecules are selected randomly for replication throughout the cell cycle","volume":"11","author":"Bogenhagen","year":"1977","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109197_bb0250","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1086\/318190","article-title":"Random genetic drift determines the level of mutant mtDNA in human primary oocytes","volume":"68","author":"Brown","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109197_bb0255","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2125.2005.02553.x","article-title":"Tadalafil pharmacokinetics in healthy subjects","volume":"61","author":"Forgue","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ymgme.2025.109197_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100941","article-title":"Uncoupling proteins in the mitochondrial defense against oxidative stress","volume":"83","author":"Hass","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109197_bb0265","first-page":"222","article-title":"Effects of tadalafil on skeletal muscle tissue: exploring interactions and novel mechanisms of action","volume":"48","author":"Antinozzi","year":"2023","journal-title":"Minerva Endocrinol (Torino)"},{"key":"10.1016\/j.ymgme.2025.109197_bb0270","first-page":"99","article-title":"Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review","volume":"10","author":"Henrie","year":"2015","journal-title":"Core Evid"}],"updated-by":[{"DOI":"10.1016\/j.ymgme.2025.109219","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000}}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922500188X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922500188X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T23:00:36Z","timestamp":1761433236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671922500188X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":54,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S109671922500188X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109197","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphodiesterase type 5 inhibition as a therapeutic strategy in primary mitochondrial disease: Evidence from patient fibroblasts and clinical observations","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109197"}}